Generational Capital Markets Advises Graham Medical Technologies in its sale to ADDvise Group AB
DALLAS–(BUSINESS WIRE)–Generational Capital Markets, Member FINRA/SIPC and a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the sale of its client, Graham Medical Technologies, LLC. to ADDvise Group AB. The acquisition closed September 15, 2021.
Located in Macomb, Michigan, Graham Medical Technologies (GraMedica) is a global medical device company and leader in new product development with medical education in orthopedics. GraMedica was founded by Dr. Michael E Graham, a successful, Michigan-based doctor of Podiatric Medicine. In his practice, Dr. Graham specialized in the correction of foot and ankle instability, a root cause of many secondary conditions throughout the body.
GraMedica is an innovator of life-changing foot and ankle products designed to provide a solution for common patient ailments. The Company’s flagship product HyProCure is a unique new implant design that rests deep within the sinus tarsi. The patented design of the HyProCure not only keeps the implants in place, it provides patients a function unmatched by any subtalar device−normal range of motion. HyProCure is a titanium subtalar stent that realigns and stabilizes the talotarsal joint.
ADDvise Group AB is a leading supplier of equipment to healthcare and research facilities. The group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB. The Company is located in Stockholm, Sweden.
Generational Capital Markets’ Senior Managing Director of Mergers & Acquisitions, Phil Pizzurro, with the support of Vice President Mergers & Acquisitions, Andre Farahmandi, successfully closed the deal. Senior Managing Director, Ashok Tandon established the initial relationship with GraMedica.
“GraMedica’s patented products helped augment ADDvise’s medical equipment and consumables business unit portfolio in addition to broadening its geographic outreach. The critical personal and cultural fit was established very early on in the process resulting in a smooth transition of ownership,” said Phil Pizzurro.
“There is undoubtedly a strong vision in which both parties align and have already made strides to maximize success for the long-term. It was a pleasure working with both sides and we look forward to witnessing the continued growth and success under the ADDvise Group AB leadership,” said Andre Farahmandi.
This is a press release from Generational Capital, LLC.